Tectonic Therapeutic, Inc. — Director's Dealing 2018

Dec 19, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2018-12-17

Reporting Person: Volck Birgitte (President of R&D)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-17	Stock Option (Right to Buy)	$21.76	A	293000	Acquired	2028-12-16	Common Stock (293000)	Direct

Footnotes

F1: 25% of the shares vest on December 17, 2019, and the remaining 75% shall vest in equal monthly installments thereafter over a three-year period.